Cytokines in Cancer Immunotherapy Virtual Workshop Schedule

Cytokines Virtual Workshop Schedule

Oct. 11–12, 2021
View On-demand Content Enduring materials are now open access. On-demand enduring materials are available as permitted by presenters. Indicates this content is not available on-demand.
Monday, Oct. 11, 2021

Session I: History of Cytokine Immunotherapy
Time:	10–11:15 a.m. EDT
10 a.m. EDT	Introduction
10:05 a.m. EDT	History of Cytokine Immunotherapy – Basic Warren J. Leonard, MD – Laboratory of Molecular Immunology, NHLBI
10:40 a.m. EDT	History of Cytokine Immunotherapy – Clinical Kim A. Margolin, MD – St. John’s Cancer Institute
Session II: Advances in IL-2/IL-15 Immunotherapy
Time:	11:15 a.m.–12:35 p.m. EDT
11:15 a.m. EDT	A Toolkit of Engineered Cytokines for Cancer Immunotherapy K. Christopher Garcia, PhD – Stanford University
11:40 a.m. EDT	IL-15 Mark Rubinstein, PhD – The Ohio State University Wexner Medical Center
12:05 p.m. EDT	Abstract Presentation
12:20 p.m. EDT	Abstract Presentation
Break
Time:	12:35–12:50 p.m. EDT
Session III: The Paradox of IL-10
Time:	12:50–2:10 p.m. EDT
12:50 p.m. EDT	Expectations and History of IL-10 Anne O' Garra, PhD, FRS, FMedSCI – The Francis Crick Institute
1:15 p.m. EDT	Clinical Data Martin Oft, MD – Synthekine
1:40 p.m. EDT	Abstract Presentation
1:55 p.m. EDT	Abstract Presentation
Session IV: Inhibitor Cytokines
Time:	2:10–3:30 p.m. EDT
2:10 p.m. EDT	TGF-beta Zihai Li, MD, PhD – The Ohio State University
2:35 p.m. EDT	IL-35 Dario A.A. Vignali, PhD – University of Pittsburgh
3:00 p.m. EDT	Abstract Presentation
3:15 p.m. EDT	Abstract Presentation
Session V: Interferons: Friend or Foe?
Time:	3:30–4:50 p.m. EDT
3:30 p.m. EDT	IFN-gamma Andy J. Minn, PhD – University of Pennsylvania
3:55 p.m. EDT	Type I Interferons John Teijaro, PhD – Scripps Research
4:20 p.m. EDT	Abstract Presentation
4:35 p.m. EDT	Abstract Presentation
4:50 p.m. EDT	Closing Remarks

Tuesday, Oct. 12, 2021

Session VI: Emerging Cytokines Therapies
Time:	10–11:25 a.m. EDT
10 a.m. EDT	Introduction
10:05 a.m. EDT	IL-18 Aaron M. Ring, MD, PhD – Yale School of Medicine
10:30 a.m. EDT	Intratumoral administration and retention of immune agonists to maximize therapeutic index K. Dane Wittrup, PhD – Koch Institute for Integrative Cancer Research at MIT
10:55 a.m. EDT	Abstract Presentation
11:10 a.m. EDT	Abstract Presentation

Session VII: Cytokines in Cell Therapies
Time:	11:25 a.m. –12:15 p.m. EDT
11:25 a.m. EDT	Adoptive Th17 Therapies Chrystal M. Paulos, PhD – The Winship Cancer Institute of Emory University
11:50 a.m. EDT	TRUCK Therapies Anthony Daniyan, MD – Memorial Sloan Kettering Cancer Center
Minute-to-Win-It Presentation
Time:	12:05–12:40 p.m. EDT
Break
Time:	12:40–12:55 p.m. EDT
Session VIII: Cytokine Activity & Innate Immunity
Time:	12:55–1:55 p.m. EDT
12:55 p.m. EDT	NK Cells David H. Raulet, PhD – University of California, Berkeley
1:20 p.m. EDT	Boosting Innate Immunity to Overcome Immunotherapy Aquired Resistance Katerina Politi, PhD – Yale School of Medicine
Session IX: Closing Keynote
Time:	1:45–2:45 p.m.
1:45 p.m. EDT	Keynote Shannon J. Turley, PhD – Genentech, Inc. (NO)
2:45 p.m. EDT	Closing Remarks

Program Access

Registrants will receive a link to access the virtual platform before the program.

Questions?

If you have questions about this program, please contact the SITC Education team.

Back to...

Cytokines Workshop HomePage

Cytokines in Cancer Immunotherapy Virtual Workshop Schedule

Cytokines Virtual Workshop Schedule

Program Access

Questions?

Back to...

Membership Links

Get Involved